Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22721657 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA-Phase 1)
Condition: Coronary Artery Disease
Intervention: Device: XIENCE V® Everolimus Eluting Coronary Stent

Indicates status has not been verified in more than two years